| Literature DB >> 3257685 |
R J Breslin1, A Barbul, T S Kupper, J P Knud-Hansen, H L Wasserkrug, G Efron.
Abstract
Previously we have noted that fluid obtained from ten-day-old healing wounds noncytotoxically inhibits the blastogenesis of lymphocytes in response to mitogens or antigens. Since these lymphocytic responses are interleukin 2 (IL-2)-mediated, we looked for a specific IL-2 inhibitor in wound fluid. We have found that wound fluid blocks the response of thymic lymphocytes and of two cloned T-helper cell lines (D10 and HT2) to exogenous human recombinant IL-2. The wound fluid enhances fibroblast proliferation, thus demonstrating that its proliferative inhibitory activity is specific for lymphocytes. The findings suggest that wound fluid contains a factor that impairs lymphocyte response to IL-2, probably at the receptor or postreceptor level.Entities:
Mesh:
Substances:
Year: 1988 PMID: 3257685 DOI: 10.1001/archsurg.1988.01400270039005
Source DB: PubMed Journal: Arch Surg ISSN: 0004-0010